Guide | Genetic Screening for Pregnancy at Age 35 and Older
Pregnancy risks increase with maternal age. Women aged 35 and older may face a higher risk of genetic or chromosomal conditions, so doctors often recommend additional prenatal genetic screening to identify potential concerns early. These tests are optional but can help expectant parents understand the baby's health and prepare for prenatal care.
Purpose of genetic screening
Pregnant women aged 35 and older generally have a higher risk of chromosomal conditions such as Down syndrome and of neural tube defects. Screening can clarify these risks and provide reassurance. If results suggest a genetic condition, parents can prepare for possible additional needs and discuss prenatal care with their doctor.
Most screening tests are safe, but some testing carries risks, and results can be false-positive or false-negative. Women should discuss each test's risks, benefits, and limitations with their doctor.
Common prenatal genetic tests
1. Ultrasound
Ultrasound is a common, noninvasive examination for all pregnant women. It uses high-frequency sound waves to help doctors assess the baby's health. It can:
Confirm pregnancy
Check for multiple pregnancy
Observe the baby's heartbeat
Estimate the due date and assess growth
View the baby's sex
Examine the uterus and ovaries
Check placental position and amniotic fluid volume
Identify congenital conditions such as cleft lip, heart defects, spina bifida, and signs associated with Down syndrome
2. First Trimester Screen
Usually performed between 11 and 14 weeks, this includes a blood test and ultrasound. The blood test measures two markers, while ultrasound measures the thickness at the back of the baby's neck. Together, they assess the risk of chromosomal conditions such as Down syndrome.
Compared with the Quad Marker Screen, first-trimester screening provides direct fetal imaging and produces fewer false positives. It may be combined with a second blood test to improve accuracy.
3. Quad Marker Screen
This blood test, usually performed between 15 and 20 weeks, measures four markers to assess the risk of neural tube defects such as spina bifida or anencephaly and chromosomal conditions such as Down syndrome. In women older than 35, it can identify more than 80% of Down syndrome cases.
The quad screen estimates risk but does not diagnose a condition. If risk exceeds the average for a 35-year-old woman, diagnostic testing such as amniocentesis or further ultrasound may be needed.
4. Amniocentesis
This diagnostic test is usually performed between 16 and 20 weeks. Guided by ultrasound, a doctor inserts a thin needle through the abdomen into the uterus and removes a small sample of amniotic fluid. The sample can diagnose chromosomal conditions such as Down syndrome, trisomy 18, trisomy 13, and Turner syndrome, as well as genetic conditions such as sickle cell anemia, cystic fibrosis, and muscular dystrophy.
5. Chorionic villus sampling (CVS)
Similar to amniocentesis, CVS is usually performed between 10 and 13 weeks. Placental chorionic villus cells are sampled to test fetal chromosomes and potential inherited conditions. CVS can identify genetic abnormalities earlier than amniocentesis but carries risk and is generally not recommended for twin pregnancies.
6. Noninvasive prenatal testing (NIPT)
NIPT is a newer blood test also called cell-free DNA testing. It analyzes fetal DNA circulating in maternal blood to assess the risk of chromosomal conditions such as Down syndrome, trisomy 18, and trisomy 13. It has a reported accuracy of 99%, higher than traditional blood screening.
Its main advantage is that it does not require sampling amniotic fluid or chorionic villi. It is usually performed between 10 and 22 weeks. If results suggest a chromosomal condition, a doctor may recommend amniocentesis or CVS to confirm the diagnosis.
Considering risks and benefits
Although these tests provide more information about fetal health, not all insurers cover NIPT. Discuss testing with a doctor and ask the insurance company about coverage.
Conclusion
Pregnancy at age 35 or older carries increased risks, and genetic screening can identify potential concerns early. Understanding each test's indications, risks, and benefits can help expectant parents make informed choices and plan prenatal care.
Guide | Genetic Screening for Pregnancy at Age 35 and Older
Guide | Genetic Screening for Pregnancy at Age 35 and Older
Pregnancy risks increase with maternal age. Women aged 35 and older may face a higher risk of genetic or chromosomal conditions, so doctors often recommend additional prenatal genetic screening to identify potential concerns early. These tests are optional but can help expectant parents understand the baby's health and prepare for prenatal care.
Purpose of genetic screening
Pregnant women aged 35 and older generally have a higher risk of chromosomal conditions such as Down syndrome and of neural tube defects. Screening can clarify these risks and provide reassurance. If results suggest a genetic condition, parents can prepare for possible additional needs and discuss prenatal care with their doctor.
Most screening tests are safe, but some testing carries risks, and results can be false-positive or false-negative. Women should discuss each test's risks, benefits, and limitations with their doctor.
Common prenatal genetic tests
1. Ultrasound
Ultrasound is a common, noninvasive examination for all pregnant women. It uses high-frequency sound waves to help doctors assess the baby's health. It can:
Confirm pregnancy
Check for multiple pregnancy
Observe the baby's heartbeat
Estimate the due date and assess growth
View the baby's sex
Examine the uterus and ovaries
Check placental position and amniotic fluid volume
Identify congenital conditions such as cleft lip, heart defects, spina bifida, and signs associated with Down syndrome
2. First Trimester Screen
Usually performed between 11 and 14 weeks, this includes a blood test and ultrasound. The blood test measures two markers, while ultrasound measures the thickness at the back of the baby's neck. Together, they assess the risk of chromosomal conditions such as Down syndrome.
Compared with the Quad Marker Screen, first-trimester screening provides direct fetal imaging and produces fewer false positives. It may be combined with a second blood test to improve accuracy.
3. Quad Marker Screen
This blood test, usually performed between 15 and 20 weeks, measures four markers to assess the risk of neural tube defects such as spina bifida or anencephaly and chromosomal conditions such as Down syndrome. In women older than 35, it can identify more than 80% of Down syndrome cases.
The quad screen estimates risk but does not diagnose a condition. If risk exceeds the average for a 35-year-old woman, diagnostic testing such as amniocentesis or further ultrasound may be needed.
4. Amniocentesis
This diagnostic test is usually performed between 16 and 20 weeks. Guided by ultrasound, a doctor inserts a thin needle through the abdomen into the uterus and removes a small sample of amniotic fluid. The sample can diagnose chromosomal conditions such as Down syndrome, trisomy 18, trisomy 13, and Turner syndrome, as well as genetic conditions such as sickle cell anemia, cystic fibrosis, and muscular dystrophy.
5. Chorionic villus sampling (CVS)
Similar to amniocentesis, CVS is usually performed between 10 and 13 weeks. Placental chorionic villus cells are sampled to test fetal chromosomes and potential inherited conditions. CVS can identify genetic abnormalities earlier than amniocentesis but carries risk and is generally not recommended for twin pregnancies.
6. Noninvasive prenatal testing (NIPT)
NIPT is a newer blood test also called cell-free DNA testing. It analyzes fetal DNA circulating in maternal blood to assess the risk of chromosomal conditions such as Down syndrome, trisomy 18, and trisomy 13. It has a reported accuracy of 99%, higher than traditional blood screening.
Its main advantage is that it does not require sampling amniotic fluid or chorionic villi. It is usually performed between 10 and 22 weeks. If results suggest a chromosomal condition, a doctor may recommend amniocentesis or CVS to confirm the diagnosis.
Considering risks and benefits
Although these tests provide more information about fetal health, not all insurers cover NIPT. Discuss testing with a doctor and ask the insurance company about coverage.
Conclusion
Pregnancy at age 35 or older carries increased risks, and genetic screening can identify potential concerns early. Understanding each test's indications, risks, and benefits can help expectant parents make informed choices and plan prenatal care.
Story source:
Compiled from online sources